...
首页> 外文期刊>Journal of neurointerventional surgery >Endovascular treatment of very small ruptured intracranial aneurysms: Complications, occlusion rates and prediction of outcome
【24h】

Endovascular treatment of very small ruptured intracranial aneurysms: Complications, occlusion rates and prediction of outcome

机译:很小的颅内破裂动脉瘤的血管内治疗:并发症,闭塞率和预后

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To assess predictors of outcome following endovascular treatment of small ruptured intracranial aneurysms (SRA). Methods Between 2004 and 2011, 91 patients with SRA (≤3 mm) were treated at our institution. Multivariate analysis was carried out to assess predictors of endovascular-related complications, aneurysm obliteration (>95%), recanalization and favorable outcome (Glasgow Outcome Scale 3-5). Results: Endovascular treatment was aborted in nine of 91 patients (9.9%). Procedure-related complications occurred in eight of 82 patients (9.8%) of which five were transient and three were permanent. Three patients (3.7%) undergoing endovascular treatment experienced an intraprocedural aneurysm rupture. Three of nine patients (33.3%) treated with stent- or balloon-assisted coiling experienced periprocedural complications compared with five of 73 patients (6.8%) receiving only coils or Onyx (p=0.039). There were no procedural deaths or rehemorrhages. Rates of recanalization and retreatment were 18.2% and 12.7%, respectively. No factors predicted initial occlusion or recanalization. In multivariate analysis, pretreatment factors predictive of a favorable outcome included younger age (OR 0.94; 95% CI 0.91 to 0.99, p=0.017), larger aneurysm size (OR 3.4; 95% CI 1.02 to 11.11, p=0.045), Hunt and Hess grade (OR 0.38; 95% CI 0.19 to 0.75, p=0.005) and location (OR 5.12; 95% CI 1.29 to 20.25, p=0.02). When assessing treatment and post-treatment variables, vasospasm was the only additional covariate predictive of a poor outcome (OR 5.90; 95% CI 1.34 to 25.93, p=0.019). Conclusions: Most patients with SRA can be treated with endovascular therapy and have limited complications. Overall predictors of outcome for patients undergoing endovascular treatment of SRA include age, aneurysm size, Hunt and Hess grade, location and posttreatment vasospasm.
机译:目的:评估血管内治疗小型颅内破裂动脉瘤(SRA)后的预后指标。方法2004年至2011年,我院收治91例SRA(≤3mm)患者。进行多变量分析以评估血管内相关并发症,动脉瘤闭塞(> 95%),再通和良好预后的预测因素(格拉斯哥预后评分表3-5)。结果:91例患者中有9例(9.9%)放弃了血管内治疗。与手术相关的并发症发生在82例患者中的8例(9.8%)中,其中5例是短暂的,3例是永久性的。接受血管内治疗的三名患者(3.7%)经历了术中动脉瘤破裂。 9例接受支架或球囊辅助卷绕的患者中有3例(33.3%)经历了围手术期并发症,而73例中只有5例(6.8%)仅接受了线圈或Onyx术(p = 0.039)。没有手术死亡或出血。再通率和再治疗率分别为18.2%和12.7%。没有因素可预测最初的阻塞或再通。在多变量分析中,可预测预后良好的预处理因素包括年龄较小(OR 0.94; 95%CI 0.91至0.99,p = 0.017),较大的动脉瘤大小(OR 3.4; 95%CI 1.02至11.11,p = 0.045),亨特和Hess等级(OR 0.38; 95%CI 0.19至0.75,p = 0.005)和位置(OR 5.12; 95%CI 1.29至20.25,p = 0.02)。在评估治疗和治疗后变量时,血管痉挛是唯一可预测不良结果的协变量(OR 5.90; 95%CI 1.34至25.93,p = 0.019)。结论:大多数SRA患者可以接受血管内治疗,并发症少。接受SRA血管内治疗的患者预后的总体预测因素包括年龄,动脉瘤大小,Hunt和Hess分级,位置和治疗后血管痉挛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号